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Neurological complications after H1N1
influenza vaccination: magnetic resonance
imaging findings
Complicações neurológicas após vacinação para H1N1: achados de ressonância
magnética.
Ronaldo Lessa1, Maurício Castillo2, Renata Azevedo3, Fernanda Azevedo4, Hildo Azevedo5
ABSTRACT
Objective: To report 4 different neurological complications of H1N1 virus vaccination. Method: Four patients (9,16, 37 and 69 years of age)
had neurological symptoms (intracranial hypertension, ataxia, left peripheral facial palsy of abrupt onset, altered mental status, myelitis)
starting 4-15 days after H1N1 vaccination. MRI was obtained during the acute period. Results: One patient with high T2 signal in the
cerebellum interpreted as acute cerebellitis; another, with left facial palsy, showed contrast enhancement within both internal auditory
canals was present, however it was more important in the right side; one patient showed gyriform hyperintensities on FLAIR with sulcal
effacement in the right fronto-parietal region; and the last one showed findings compatible with thoracic myelitis. Conclusion: H1N1
vaccination can result in important neurological complications probably secondary to post-vaccination inflammation. MRI detected
abnormalities in all patients.
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RESUMO
Objetivo: Relatar quatro diferentes complicações neurológicas da vacina contra o vírus H1N1. Método: Quatro pacientes (9, 16, 37 e 69
anos) tinham sintomas neurológicos (hipertensão intracraniana, ataxia, paralisia facial esquerda de inicio abrupto, estado mental alterado
e mielite) iniciando-se 4 a 15 dias após vacinação contra H1N1. RM foi realizada em quatro pacientes na fase aguda e em um paciente na
fase crônica. Resultados: Dos quatro pacientes, um apresentou hipersinal em T2 no cerebelo, interpretado como cerebelite aguda; um,
com paralisia facial esquerda, tinha realce dos condutos auditivos internos, maior à direita; um tinha hipersinal em T2 no cortex parieto-
occipital direito; um apresentou sinais compatíveis com mielite torácica. Conclusão: A vacinação contra o H1N1 pode resultar em
importantes complicações neurológicas, provavelmente secundárias a inflamação pós-vacinal. A RM detectou anormalidades em todos
os pacientes.
Palavras-chave: sistema nervoso central, virus influenza H1N1, imagem de ressonância magnética, encefalite pós-vacinal.
Neurological complications of influenza occur in about
4:100,000 of patients per year1. Encephalitis due to H1N1
influenza has been described with the first report dating
back to the 1918 influenza pandemia2,3,4,5,6. The most common
clinical findings of encephalitis are high fever, seizures, intra-
cranial hypertension, altered consciousness, and coma7,8.
Although some encephalitis patients fully recover without
any neurological sequelae, about 30% die8. In influenza-
related encephalitis neuroimaging studies may be normal,
but T2 and T2 FLAIR hyperintense lesions in the white
matter and thalami, cerebral edema, hemorrhages, and a
pattern similar to that of acute necrotizing encephalitis have
been described9,10.
Vaccination is an important prophylaxis against H1N1
influenza decreasing the infection rate and preventing severe
complications11. Although rare, CNS complications of vac-
cination against H1N1 influenza may occur. In this article
we describe the clinical and neuroimaging findings in 4
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patients who developed variety of imaging manifestations
that are different from those of other reports describing
complications after H1N1 influenza vaccination.
METHOD
Patients and MR Studies
We reviewed imaging findings in 4 patients (age range:
9-69 years) who were vaccinated against H1N1 influenza.
Neurologic symptoms started, on average, 9.8 days (range:
4-15 days) after vaccination and unlike other case series clin-
ical presentations in our patients were protean. All four
patients underwent brain MRI within the first week of symp-
toms. The patients had a minimum of sagittal and axial non-
contrast T1 images, axial T2 and T2 FLAIR images, and axial
and coronal post contrast T1 images. One patient, who
has been previously reported in the literature by 1 of us,
received pre (sagittal T1, T2, and STIR and axial T1) and post
contrast (sagittal and axial T1) imaging of the cervical and
thoracic spine12.
Case 1
A 16-year-old girl presented with headaches, vomiting,
and cerebellar ataxia, which had developed over 24 hours.
There was no history of viral infection or other associated
disorders except that she had been vaccinated against
H1N1 12 days before. Laboratory tests including CSF ana-
lysis showed no significant abnormalities.
Brain MRI showed cortical foci of hyperintensity on
FLAIR in the cerebellar hemispheres with significant mass
effect on the 4th ventricle and distal aspect of the cerebral
aqueduct with resulting hydrocephalus (Figures 1A and
1C). The supratentorial brain was normal with the exception
of ventricular dilatation.
The patient was treated with corticosteroids and follow-
up MRI one week later showed decreased hydrocephalus.
After 60 days, clinical examination showed that the patient’s
ataxia and headaches had resolved. Follow up MRI showed
a significant regression of the abnormalities. No further
imaging follow up was deemed necessary.
Case 2
A 9-year-old boy presented with a left peripheral facial
palsy of abrupt onset. He had no history of viral illness, head-
ache, vomiting, fever or other neurological symptoms but he
had been vaccinated against H1N1 9 days prior to the onset
of the facial palsy. Laboratory tests including CSF analysis
were normal.
Brain MRI showed contrast enhancement in both
internal auditory canals and in the labyrinthic and petrous
portions of the facial nerves, more marked on the right side
(Figures 2A and 2C). No other abnormalities were seen. He
was treated with corticosteroids and significant improve-
ment in his facial palsy was observed 8 days later. No follow
up MRI was obtained.
Figure 1. Axial FLAIR (A) and corresponding post contrast T1 image (B) show areas of high signal in both gray and white
matter without enhancement. Note mass effect compressing the 4th ventricle. Axial T2 weighted images show areas of high signal
and mass effect on the 4th ventricle and distal aspect of the cerebral aqueduct with resulting hydrocephalus (C-D).
Figure 2. Axial T1 post contrast shows enhancement in the
right internal auditory canal (white arrow). Contrast enhance-
ment in the opposite side is not shown.
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Case 3
A 69-year-old woman presented with behavioral changes
and declining mental status with no focal neurologic symp-
toms. The patient had been vaccinated against H1N1 15 days
before the onset of neurological symptoms. Brain MRI showed
gyriform hyperintensities on FLAIR with sulcal effacement
in the right fronto-parietal region (Figures 3A and 3C). No
other abnormalities or contrast enhancement were noted.
The patient was treated with corticosteroids resulting in
improvement of the neurological signs. MRI follow-up 4
weeks later was normal.
Case 4
A 37-year-old female presented with fever and ascending
paresthesias which started in her legs and progressed to a
T3 level 4 days after H1N1 vaccination. MRI of the spine
showed a focal short area of high T2 signal and cord expan-
sion at C6-7 (Figure 4) with little if any contrast enhance-
ment (not shown). CSF analysis was normal (including
herpes virus, CMV, oligoclonal bands and others) and con-
servative treatment was prescribed. One month later symp-
toms had resolved and follow up MRI showed complete
resolution of findings.
DISCUSSION
The H1N1 virus of influenza type A is a combination of
several genetics segments of the human, avium, and swine
virus that traditionally infect pigs but may spread to humans
as thus it is categorized as a “variant” virus13. Only 16 cases
of H1N1 infection have been documented in the USA since
200514. But in 2009 the World Health Organization declared a
global H1N1 influenza pandemia. Complications following
H1N1 infection may occur and the most common are those
involving the respiratory tract. Neurological complications
may be seen in up 10% of children with H1N1 infection
the most common include acute disseminated encephalo-
myelitis (ADEM), acute necrotizing encephalitis (ANEC),
influenza encephalitis, and Guillain-Barré syndrome have
also been described13,15,16,17,18,19.
H1N1 vaccination is an important prophylatic tool
to decrease the incidence, intensity, and morbidity of the
disease20. Cases of different types of encephalitis and
myelitis after vaccination against the H1N1 have been
described4,10,11,20,21. The pathogenesis of this encephalitis is
not yet fully explained and is believed that immune-
mediated alterations resulting in the production of
Figure 3. Axial T2 FLAIR and Coronal T2 images show mild gyriform hyperintensities with sulcal effacement in the right fronto-
parietal gray matter and some hyperintensities in the white matter of the opposite hemisphere which were thought to be related to
small vessel disease (A–B).
Figure 4. Midsagittal T2 image in the cervical spine shows a
focal, well-defined hyperintense region (arrow) at the C6-7
level (used with permission from: Docampo J, Mariluis C,
Castillo M, Bruno C, Morales C. Mielitis transversa asociada a
vacinacion antigripal. RAR 2011; 75: 15-18).
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antibodies and/or the emergence of de novo inflammatory
process are responsible20,21,22. Types of encephalitis seen
after vH1N1 vaccination include a non-specific pattern,
an ADEM pattern, an ANEC pattern, and an influenza-like
pattern. Clinical presentations of CNS complications of
H1N1 vaccination can be diverse as seen in our patients
but the most common symptom are seizures which were
not seen in any of our patients. Our first patient presented
cerebellar ataxia and intracranial hypertension as a result
of diffuse cerebellar edema and hydrocephalus. The second
patient was a boy with left facial palsy in whom MRI
showed bilateral facial nerve involvement. The third
patient presented with behavioral changes and a decline
in mental status. All were treated with steroids and showed
significant imaging and clinical improvement. The fourth
case was a 37 year old woman with cervical medullary
involvement in whom symptoms resolved spontaneously
4 weeks after and a follow up MRI was normal. We
believe that our cases are worth reporting because the
clinical and imaging manifestations were varied and different
to those reported in larger series implying the complications
of H1N1 vaccination could be more protean than previously
described.
Although our patients were only evaluated with conven-
tional MRI sequences, one report describes the use of MR
spectroscopy (MRS) in the setting of acute H1N1-related
encephalitis23. In that article, 10 patients were assessed with
MRS which showed minimal and non-specific metabolic
alterations with only a slight elevation of taurine seen; a find-
ing of uncertain significance.
Based on this small series of patients and other reported
cases, encephalitis is the most common, albeit rare, complica-
tion of H1N1 vaccination and although as seen in 3 patients
reported herein, cerebellitis, neuritis and myelitis may also
occur. MRI is the imaging method of choice to assess the
finding which tend to be non-specific but are related in time
with the vaccine administration. As seen in our cases, most
patients will have a favorable prognosis. We concluded that
CNS involvement of H1N1 vaccination related complications
is more varied than previously reported.
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